SUMMARY Six subjects (three female, three male; age range 38-85 years) with adult onset hypophosphatasia are described. Three presented atypically with calcific periarthritis (due to apatite) in the absence of osteopenia; two had classical presentation with osteopenic fracture; and one was the asymptomatic father of one of the patients with calcific periarthritis. All three subjects over age 70 had isolated polyarticular chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition; four of the six had spinal hyperostosis, extensive in two (Forestier's disease). The apparent paradoxical association of hypophosphatasia with calcific periarthritis and spinal hyperostosis is discussed in relation to the known effects of inorganic pyrophosphate on apatite crystal nucleation and growth.
Hypophosphatasia is a rare inherited disorder characterised by low serum levels of alkaline phosphatase, raised urinary phosphoethanolamine excretion, and increased serum and urinary concentrations of inorganic pyrophosphate.'" Clinical presentation classically takes one of three forms according to age: failure to thrive with high mortality in infancy, a condition resembling childhood rickets, or multiple fractures due to severe osteopenia in adults.' Disease severity is variable, especially in adult forms.' 2 An association with premature, polyarticular chondrocalcinosis due to calcium pyrophosphate dihydrate (CPPD) crystal deposition is well described.7 Figure 1 outlines the suggested mechanisms for the osteopenia and chondrocalcinosis characteristic of this disorder. The major biological source of inorganic pyrophosphate (PPi) derives from pyro 
571
PPi ionic product, predisposing to enhanced CPPD crystal deposition in cartilage.
Paradoxical presentation with calcific periarthritis-that is, excess apatite, in three adults with biochemical hypophosphatasia but no osteopenia prompted us to re-examine these postulates. Findings in these cases are contrasted with those in two elderly patients with more classic hypophosphatasia presenting with severe osteopenia and multiple fractures, and the asymptomatic father of one of the patients with calcific periarthritis. crystal deposition: lack of alkaline phosphatase results in increased inorganic pyrophosphate (PPi), which then inhibits apatite formation and growth and also predisposes to CPPD crystal formation. Crystal deposition in hypophosphatasia 573
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around the left wrist. The radiograph showed discrete nummular calcification overlying the left carpus (Fig. 3) , and needle aspiration showed calcific material with a spectrum on infrared spectroscopy consistent with carbonated hydroxyapatite. His acute inflammation settled on treatment with non-steroidal anti-inflammatory drugs alone, and a repeat wrist radiograph at 10 days, just before his return to Poland, showed considerable dispersal of the calcification (Fig. 3) 22 Although severe osteopenia is the expected consequence of hypophosphatasia, calcific periarthritis with normal bone density in three of our patients suggests that in certain situations low alkaline phosphatase levels may associate with stimulation rather than inhibition of apatite formation or growth. In vitro study of calcification mechanisms in epiphyseal growth cartilage10 12 13 15 16 shows that at high concentration PPi is a potent inhibitor of apatite: adsorption of PPi onto the amorphous calcium/phosphate complex prevents transformation to crystalline hydroxyapatite, and adsorption onto apatite crystals inhibits aggregation and growth.8 1016 At lower concentrations, however, PPi promotes apatite crystal transformation and growth.10 12 15 16 Inorganic pyrophosphate is conspicuously present in mineralising tissues and is thought by its dual effect to be a physiological regulator of matrix vesicle calcification. 15 Although osteoarticular concentrations were not assessed, it is conceivable that tissue PPi concentrations were in the range to stimulate apatite nucleation and growth in the three patients with calcific periarthritis (ectopic apatite), normal bone density, and modestly low serum alkaline phosphatase (mean (SD) 64-3 (7-5) U/l), whereas in those with osteopenia (insufficient apatite) and lower alkaline phosphatase levels (39-5 (12) 36 and Wilson's disease.37 Such similarity supports predisposition by effects on PPi metabolism-for example, inhibition of alkaline phosphatase by calcium, cupric, and ferrous ions38; reduction in magnesium as co-factor for alkaline phosphatase39; stimulation of adenylate cyclase by parathyroid hormone.8 39 By contrast, in haemochromatosis (another predisposing metabolic disease), although isolated chondrocalcinosis may occur, chronic symptoms with arthropathic change (cartilage/bone attrition, prominent cysts; distinctive distribution; often no overt synovitis) are more usual,4 41 suggesting that other non-PPi related mechanisms may be involved in predisposition to chondrocalcinosis and arthropathy. 
